U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06931015) titled 'Staging Heart Failure With Preserved Ejection Fraction' on April 09.
Brief Summary: Heart failure with preserved ejection fraction (HFpEF) is considered a systemic condition in which the prevalence of cardiovascular, metabolic, pulmonary and renal conditions determine the extent of cardiac involvement. Numerous attempts have been made to phenotype HFpEF, but we still lack a clinically and/or prognostically relevant approach.
Progressive cardiac deterioration in HFpEF appears to be associated with a worse prognosis. However, no attempt has been made to classify the extent of cardiac involvement in HFpEF. We proposed the concept of ...